CATALINA LETTICH: Open Payments
NPI 1851061501 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,887 in 110 payments from 16 companies in 2025. Trend: 2023 $1,089 · 2024 $1,558 · 2025 $1,887
Food & beverage: $1,887
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $441 |
| ABBVIE INC. | 32 | $404 |
| PFIZER INC. | 13 | $211 |
| Novo Nordisk Inc | 7 | $150 |
| GlaxoSmithKline, LLC. | 11 | $146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $141 |
| Axsome Therapeutics, Inc. | 4 | $85 |
| Xeris Pharmaceuticals, Inc. | 4 | $78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $67 |
| Sumitomo Pharma America, Inc. | 3 | $56 |
Products named: NURTEC ODT, AIRSUPRA, QULIPTA, TRELEGY ELLIPTA, CAPLYTA, LINZESS, ENHERTU, Ozempic.
Industry payments across TN — which companies pay providers there.
